S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
Europe
EU
Abivax (ABVX)
Abivax (ABVX) Financials

Abivax (ABVX)

7.83

-0.33

(-4.04%)

Closed November 26 10:30AM

Delayed by 15 minutes

Abivax Financial Summary

The current ABVX market cap is 492.73M. The company's latest EPS is EUR -2.3477 and P/E is -3.34.

Income Statement

Year End December 30 2023	2019	2020	2021	2022	2023
	EUR (€)	EUR (€)	EUR (€)	EUR (€)	EUR (€)
Total Revenue	23k	6.75M	11.96M	4.58M	4.62M
Operating Income	-33.3M	-33.17M	-41.4M	-64.84M	-127.38M
Net Income	-30.63M	-37.63M	-42.45M	-60.74M	-147.74M

Balance Sheet

Year End December 30 2023	2019	2020	2021	2022	2023
	EUR (€)	EUR (€)	EUR (€)	EUR (€)	EUR (€)
Total Assets	51.73M	69.71M	109.23M	75.54M	327.06M
Total Liabilities	39.95M	67.98M	83.3M	68.36M	131.05M
Total Equity	11.78M	1.73M	25.93M	7.19M	196.01M

Cash Flow

Year End December 30 2023	2019	2020	2021	2022	2023
	EUR (€)	EUR (€)	EUR (€)	EUR (€)	EUR (€)
Operating	-27.47M	-27.99M	-45.05M	-53.94M	-97.13M
Investing	-370k	-513k	-6.23M	-12.03M	-8.1M
Financing	24.61M	48.03M	82.68M	32.21M	335.29M

Stats and Ratios

Market Cap	492.73M
Price to Earnings Ratio	-3.34
Price to Sales Ratio	106.68
Price to Cash Ratio	1.96
Price to Book Ratio	2.51
Dividend Yield	-

Share Statistics

Shares Outstanding	62.93M
Average Volume (1 week)	22.51k
Average Volume (1 Month)	17.1k
52 Week Change	-17.58%
52 Week High	15.42
52 Week Low	7.59
Spread (Intraday)	0.53 (6.56%)

Company Info

Company Name	Abivax
Address	7-11 boulevard haussmann paris, paris 75009
Website	https://www.abivax.com
Industry	pharmaceutical preparations (2834)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions